Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them?

Nicotine and Tobacco Research

Volumn 6, Issue SUPPL. 3, 2004, Pages

  Bansal, Maansi A ^a   Cummings, K Michael ^a   Hyland, Andrew ^a   Giovino, Gary A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE DERIVATIVE; NICOTINE GUM;

ADULT; ARTICLE; AWARENESS; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG EFFICACY; DRUG MISUSE; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HEALTH HAZARD; HEALTH SURVEY; HEART INFARCTION; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NICOTINE REPLACEMENT THERAPY; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING HABIT; TELEPHONE; TOBACCO DEPENDENCE;

ADULT; ATTITUDE TO HEALTH; FEMALE; HARM REDUCTION; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; QUESTIONNAIRES; RISK FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE DISORDER; UNITED STATES;

EID: 12344296677     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200412331320707     Document Type: Article

References (15)

1. American Association for Public Opinion Research. (2000). Standard definitions: Final deposition case codes and outcome rates for surveys. Ann Arbor, MI: The American Association for Public Opinion Research.
2. Benowitz, N. L. (1988). Pharmacologic aspects of cigarette smoking and nicotine addiction. New England Journal of Medicine, 319 1318-1330.
3. Benowitz, N. L. (1998). Nicotine Safety and Toxicity. New York: Oxford University Press.
4. Centers for Disease Control and Prevention. (2000). Use of FDA-Approved Pharmacologic Treatments for Tobacco Dependence - United States, 1984-1988. Morbidity and Mortality Weekly Report, 49, 665-668.
5. Cummings, K. M., Hyland, A., Giovino, G. A., Hastrup, J., Bauer, J., & Bansal, M. A. (2004). Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine & Tobacco Research, 6(Suppl. 3), S333-S340.
6. Curry, S. J., Grothaus, L. C., McAfee, T., & Pabiniak, C. (1998). Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. New England Journal of Medicine., 339, 673-679.
7. Etter, J. F., & Perneger, T. V. (2001). Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clinical Pharmacology & Therapeutics, 69, 175-183.
8. Hughes, J. R., Shiffman, S., Callas, P., & Zhang, J. (2003). A metaanalysis of the efficacy of over-the-counter nicotine replacement. Tobacco Control, 12, 21-27.
9. Pierce, J. P., & Gilpin, E. A. (2002). Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. Journal of the American Medical Association, 288 1260-1264.
10. Royal College of Physicians. (2000). Nicotine Addiction in Britain: A report of the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians.
11. Silagy, C., Mant, D., Fowler, G., & Lancaster, T. (2002). Nicotine replacement therapy for smoking cessation. [Update in Cochrane Database Syst Rev. 2002;(4):CD000146; PMID: 12519537] [update of Cochrane Database Syst Rev. 2000;(3):CD000146; PMID: 10908462]. [Review] [174 refs]. Cochrane Database of Systematic Reviews. (3):CD000146, 2001.
12. Thorndike, A. N., Biener, L., & Rigotti, N. A. (2002). Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. American Journal of Public Health, 92, 437-442.
13. U.S. Department of Commerce, Census Bureau. (2001). National Cancer Institute Sponsored Tobacco Use Supplement to the Current Population Survey (1998-1999). [Data file]. Available from http://www.census.gov/apsd/techdoc/cps/cpsmay99.pdf.
14. U.S. Department of Health and Human Services. (1988). The health consequences of smoking: Nicotine addiction. A report of the Surgeon General (DHHS publication no. (CDC) 88-8406). Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health.
15. West, K. A., Brognard, J., Clark, A. S., Linnoila, I. R., Yang, X., Swain, S. M., Harris, C., Belinsky, S., & Dennis, P. A. (2003). Rapid activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. The Journal of Clinical Investigation, 111, 81-90.